Zoetis | ZTS - Net Income



Zoetis reported $718M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Align Technology USD 124.61M 31.38M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Charles River Laboratories USD 52.33M 26.86M Jun/2025
Dentsply International USD -45000000 65M Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Henry Schein USD 86M 24M Jun/2025
Idexx Laboratories USD 293.99M 51.31M Jun/2025
Illumina USD 235M 104M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Laboratory Of America USD 237.9M 25.1M Jun/2025
Merck USD 4.43B 652M Jun/2025
Neogen USD -612196000 601.24M May/2025
Pacira USD -4847000 9.66M Jun/2025
Perrigo USD -8400000 2M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Quest Diagnostics USD 282M 62M Jun/2025
Sanofi EUR 3.94B 2.07B Jun/2025
Sanofi EUR 3.94B 3.44B Jun/2025
Zoetis USD 718M 87M Jun/2025